Apple and Aetna are discussing offering free or heavily discounted Apple Watches to Aetna’s 23M members. Keep in mind Apple sold around 12-15M units in 2016 (depending on whose numbers you look at). This is one example of why I think most analysts vastly underestimate the market size for wearables. Just one deal like this would greatly increase unit volume and revenue for Apple Watch specifically, but the wearables category in general. Here.
The myth of general purpose wearables, great perspective here from Bob O’Donnell: “In the end, though, dispelling the myth that wearables can or should be general purpose devices could, ironically, be the very thing that helps them finally reach the wider audience that many originally thought they could.” Here.
Fossil’s stock price dropped 25% at one point last week because of weak earnings report. Their strategy of offsetting declining revenues from traditional watches with revenue/growth from wearables and connected watches has not yet shown results, but Fossil remains committed to the strategy. Here.
LVL Technologies product that is trying to measure hydration has been delayed again, this time until summer of 2018 (Here.). Backers of the Kickstarer project are unsurprisingly unhappy, but they should be happy the company received a $6.5M investment from Samsung and Maxim, which greatly improves the chances the product will ever get to market. Here.
More details of the upcoming Samsung wearable have emerged – targeted toward sports & fitness and using Tizen OS just like other Samsung wearables, so likely no shift to Android Wear as some had thought. Here and Here.
Details from the pitch deck for Jawbone’s planned pivot to medical wearables have emerged via Bloomberg. Speculative plans included medical-grade wearable to track hydration, respiration, blood pressure, and alcohol levels. It all seems very much in line with Jawbone’s track record of selling grand ambitious visions with extremely challenging execution paths. Here.
Fascinating research on Tissue Nanotransfection (TNT)—uses nanotechnology to actively reprogram a person’s cellular makeup. By simply placing the chip on a wound, the device sends an electrical pulse designed to convert living cells into whatever necessary cells the body requires. Tests have not been done on humans yet, but the technology is currently waiting on FDA approval and will likely enter human trials within the next year. Here.
Not specific to wearables, but Apple received a patent grant that shows their continued interest in health. The patent shows how the iPhone could be used as a health sensor to detect “blood pressure index, blood hydration, body fat content, oxygen saturation, pulse rate, perfusion index, electrocardiogram, photoplethysmogram, and/or any other such health data.” Here.
Google also showed it’s continued interest in health by acquiring Senosis, which was trying to turn smartphones into monitoring devices that collect health metrics to diagnose pulmonary function, hemoglobin counts and other critical health information. Here.
Tractica released it’s latest wearable market research this week with expected growth to 430M units by 2022. Here.
NPD released data on smartwatch sales in the US. They expect US smartwatch ownership to go from 9% to 15% by end of 2018, driven by new product introductions by market leaders. Here.